1.
Ma P, Laibinis HH, Ernst CM, Hung DT. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate. Antimicrob Agents Chemother. 2018;62(11). doi:10.1128/AAC.01281-18.
1.
Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives T1 cell induction and inflammation. Science. 2017;358(6361):359-365. doi:10.1126/science.aan4526.
1.
Kanjilal S, Sater MRA, Thayer M, et al. Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014. J Clin Microbiol. 2018;56(1). doi:10.1128/JCM.01160-17.
1.
Gutierrez A, Jain S, Bhargava P, Hamblin M, Lobritz MA, Collins JJ. Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics. Mol Cell. 2017;68(6):1147-1154.e3. doi:10.1016/j.molcel.2017.11.012.
1.
Mellon G, Turbett SE, Worby C, et al. Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers. N Engl J Med. 2020;382(14):1372-1374. doi:10.1056/NEJMc1912464.
1.
Chavez A, Pruitt BW, Tuttle M, et al. Precise Cas9 targeting enables genomic mutation prevention. Proc Natl Acad Sci U S A. 2018;115(14):3669-3673. doi:10.1073/pnas.1718148115.
1.
Clatworthy AE, Romano KP, Hung DT. Whole-organism phenotypic screening for anti-infectives promoting host health. Nat Chem Biol. 2018;14(4):331-341. doi:10.1038/s41589-018-0018-3.
1.
Anyansi C, Keo A, Walker BJ, et al. QuantTB - a method to classify mixed Mycobacterium tuberculosis infections within whole genome sequencing data. BMC Genomics. 2020;21(1):80. doi:10.1186/s12864-020-6486-3.
1.
Lopatkin AJ, Bening SC, Manson AL, et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science. 2021;371(6531). doi:10.1126/science.aba0862.
1.
Ma P, He LL, Pironti A, et al. Genetic determinants facilitating the evolution of resistance to carbapenem antibiotics. Elife. 2021;10. doi:10.7554/eLife.67310.